EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization

Seyedeh Negin Kassaee iD, Godwin A Ayoko, Derek Richard, Tony Wang iD, Nazrul Islam iD

Pharmaceutics · 12.08.2024 · 16 (8) · 1061

DOI: 10.3390/pharmaceutics16081061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 12.08.2024. Verfasst von Seyedeh Negin Kassaee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Discipline, School of Clinical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ivermectin (IVM), a drug originally used for treating parasitic infections, is being explored for its potential applications in cancer therapy. Despite the promising anti-cancer effects of IVM, its low water solubility limits its bioavailability and, consequently, its biological efficacy as an oral formulation. To overcome this challenge, our research focused on developing IVM-loaded lipid polymer hybrid nanoparticles (LPHNPs) designed for potential pulmonary administration. IVM-loaded LPHNPs were developed using the emulsion solvent evaporation method and characterized in terms of particle size, morphology, entrapment efficiency, and release pattern. Solid phase characterization was investigated by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA). Using a Twin stage impinger (TSI) attached to a device, aerosolization properties of the developed LPHNPs were studied at a flow rate of 60 L/min, and IVM was determined by a validated HPLC method. IVM-loaded LPHNPs demonstrated spherical-shaped particles between 302 and 350 nm. Developed formulations showed an entrapment efficiency between 68 and 80% and a sustained 50 to 60% IVM release pattern within 96 h. Carr’s index (CI), Hausner ratio (HR), and angle of repose (θ) indicated proper flowability of the fabricated LPHNPs. The in vitro aerosolization analysis revealed fine particle fractions (FPFs) ranging from 18.53% to 24.77%. This in vitro study demonstrates the potential of IVM-loaded LPHNPs as a delivery vehicle through the pulmonary route.

Schlagwörter

Stichwörter der Autor:innen

Ivermectindry powder inhalerlipid polymer hybrid nanoparticleslung cancerpulmonary drug delivery

Autor:innen und Institutionen

  • Pharmacy Discipline, School of Clinical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
  • School of Chemistry and Physics, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
  • Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
  • Central Analytical Research Facility, Institution for Future Environment, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
  • Centre for Materials Science, Queensland University of Technology, Brisbane, QLD 4000, Australia.
  • Centre for Immunology and Infection Control (CIIC), Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.

ORCID-Profile: Seyedeh Negin Kassaee, Tony Wang, Nazrul Islam

Zitieren

APA

Kassaee, S. N., Ayoko, G. A., Richard, D., Wang, T., & Islam, N. (2024). Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization. Pharmaceutics, 16(8), 1061. https://doi.org/10.3390/pharmaceutics16081061

Vancouver

Kassaee SN, Ayoko GA, Richard D, Wang T, Islam N. Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization. Pharmaceutics. 2024;16(8):1061. doi:10.3390/pharmaceutics16081061

BibTeX
@article{Kassaee2024,
  author = {Kassaee, Seyedeh Negin and Ayoko, Godwin A and Richard, Derek and Wang, Tony and Islam, Nazrul},
  title = {Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {8},
  pages = {1061},
  doi = {10.3390/pharmaceutics16081061}
}
Kostenlos starten →